BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8462109)

  • 1. Characterization of lymphokine-activated killing by human peripheral blood mononuclear cells stimulated with interleukin 2 (IL-2) analogs specific for the intermediate affinity IL-2 receptor.
    Heaton KM; Ju G; Morris DK; Delisio K; Bailon P; Grimm EA
    Cell Immunol; 1993 Mar; 147(1):167-79. PubMed ID: 8462109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human interleukin 2 analogues that preferentially bind the intermediate-affinity interleukin 2 receptor lead to reduced secondary cytokine secretion: implications for the use of these interleukin 2 analogues in cancer immunotherapy.
    Heaton KM; Ju G; Grimm EA
    Cancer Res; 1993 Jun; 53(11):2597-602. PubMed ID: 8495422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells.
    Kasid A; Bell GI; Director EP
    J Immunol; 1988 Jul; 141(2):690-8. PubMed ID: 3133414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of lymphokine-activated killing with reduced secretion of interleukin-1 beta, tumor necrosis factor-alpha, and interferon-gamma by interleukin-2 analogs.
    Heaton KM; Ju G; Grimm EA
    Ann Surg Oncol; 1994 May; 1(3):198-203. PubMed ID: 7842289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unexpected effects of the IL-2 receptor alpha subunit on high affinity IL-2 receptor assembly and function detected with a mutant IL-2 analog.
    Kuziel WA; Ju G; Grdina TA; Greene WC
    J Immunol; 1993 Apr; 150(8 Pt 1):3357-65. PubMed ID: 8468475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of IL-15 with the shared IL-2 receptor beta and gamma c subunits. The IL-15/beta/gamma c receptor-ligand complex is less stable than the IL-2/beta/gamma c receptor-ligand complex.
    de Jong JL; Farner NL; Widmer MB; Giri JG; Sondel PM
    J Immunol; 1996 Feb; 156(4):1339-48. PubMed ID: 8568232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the relative roles of interleukin-2 and interleukin-10 in the generation of lymphokine-activated killer cell activity.
    Spagnoli GC; Juretic A; Schultz-Thater E; Dellabona P; Filgueira L; Hörig H; Zuber M; Garotta G; Heberer M
    Cell Immunol; 1993 Feb; 146(2):391-405. PubMed ID: 8174177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-12 synergizes with interleukin-2 to generate lymphokine-activated killer activity in peripheral blood mononuclear cells cultured in ovarian cancer ascitic fluid.
    Barton DP; Blanchard DK; Duan C; Roberts WS; Cavanagh D; DeCesare S; Djeu JY
    J Soc Gynecol Investig; 1995; 2(6):762-71. PubMed ID: 9420887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of human lymphokine-activated killer cells following an IL-2 pulse in elderly cancer patients.
    Provinciali M; Di Stefano G; Stronati S; Fabris N
    Cytokine; 1998 Feb; 10(2):132-9. PubMed ID: 9512903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human monocytes inhibit lymphokine-activated killer cell expansion in vitro.
    Triozzi PL; Aldrich WA; Rinehart JJ
    Mol Biother; 1991 Mar; 3(1):22-5. PubMed ID: 2069757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of lymphotoxin in the IL-2-driven differentiation of human lymphokine-activated T-killer (T-LAK) cells in vitro.
    Abe Y; Van Eden M; Gatanaga M; Wang FI; Brightbill HD; Granger GA; Gatanaga T
    Lymphokine Cytokine Res; 1993 Oct; 12(5):279-83. PubMed ID: 8260536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergy of human recombinant interleukin 1 with interleukin 2 in the generation of lymphokine-activated killer cells.
    Crump WL; Owen-Schaub LB; Grimm EA
    Cancer Res; 1989 Jan; 49(1):149-53. PubMed ID: 2783241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphokine-activated killer (LAK) cell generation from peripheral blood stem cells by in vitro incubation with low-dose interleukin-2 plus granulocyte-macrophage colony-stimulating factor.
    Herrera C; García-Pérez MJ; Ramirez R; Martín C; Alvarez MA; Martinez F; Gómez P; García-Castellano JM; Torres A
    Bone Marrow Transplant; 1997 Mar; 19(6):545-51. PubMed ID: 9085733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gammadelta T cells from glioblastoma patients.
    Fujimiya Y; Suzuki Y; Katakura R; Miyagi T; Yamaguchi T; Yoshimoto T; Ebina T
    Clin Cancer Res; 1997 Apr; 3(4):633-43. PubMed ID: 9815731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirement of thiol compounds as reducing agents for IL-2-mediated induction of LAK activity and proliferation of human NK cells.
    Yamauchi A; Bloom ET
    J Immunol; 1993 Nov; 151(10):5535-44. PubMed ID: 8228244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant interleukin 4 (RIL4) inhibits interleukin 2-induced activation of peripheral blood lymphocytes.
    Han X; Itoh K; Balch CM; Pellis NR
    Lymphokine Res; 1988; 7(3):227-35. PubMed ID: 3263554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of lymphokine-activated killer cells by human pulmonary macrophages: discordance between up-regulation of the beta chain (p75) of the interleukin-2 receptor on CD56+ cells and limited response to interleukin-2.
    Yarbrough WC; Wilkes DS; Weissler JC
    Am J Respir Cell Mol Biol; 1994 Feb; 10(2):184-91. PubMed ID: 7509162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphokine-activated killer (LAK) precursor cell activity is present in infused peripheral blood stem cells and in the blood after autologous peripheral blood stem cell transplantation.
    Neubauer MA; Benyunes MC; Thompson JA; Bensinger WI; Lindgren CG; Buckner CD; Fefer A
    Bone Marrow Transplant; 1994 Mar; 13(3):311-6. PubMed ID: 7911048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-fungal and cytokine producing activities of CD8 + T lymphocytes from HIV-1 infected individuals.
    Colón MD; Toledo N; Valiente CL; Rodríguez N; Yano N; Mathews H; Yamamura Y
    Bol Asoc Med P R; 1998; 90(1-3):21-6. PubMed ID: 9734153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental study on IL-6 activity against tumor: I. Regulation of IL-2-induced LAK cells].
    Lu LS
    Zhonghua Zhong Liu Za Zhi; 1992 Jul; 14(4):250-2. PubMed ID: 1396071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.